Novel coronavirus pneumonia
Showing 1 - 25 of >10,000
Novel COVID-19-Infected Pneumonia Trial in Changsha (Jaktinib HCl tablets)
Not yet recruiting
- Novel COVID-19-Infected Pneumonia
- Jaktinib hydrochloride tablets
-
Changsha, Hunan, ChinaChangsha Taihe Hospital
Jan 9, 2023
Novel COVID-19-Infected Pneumonia Trial in Chengdu (Jaktinib HCl tablets)
Not yet recruiting
- Novel COVID-19-Infected Pneumonia
- Jaktinib hydrochloride tablets
-
Chengdu, Sichuan, ChinaWest China Hospital Sichuan University
Jan 9, 2023
COVID-19 Pneumonia, Pneumonia Trial in Shenzhen (Jaktinib HCl tablets, Placebo)
Not yet recruiting
- COVID-19 Pneumonia
- Pneumonia
- Jaktinib hydrochloride tablets
- Placebo
-
Shenzhen, Guangdong, ChinaThe Third People Hospital of Shenzhen
Jan 26, 2023
Novel Coronavirus Pneumonia Trial in Xinxiang (NK Cells)
Recruiting
- Novel Coronavirus Pneumonia
- NK Cells
-
Xinxiang, Henan, ChinaThe First Affiliated Hospital of Xinxiang Medical University
Aug 31, 2022
Covid19, Novel Coronavirus Pneumonia, Acute Respiratory Distress Syndrome Trial in Panorama City (MSC-exosomes delivered
Not yet recruiting
- Covid19
- +2 more
- MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)
- +2 more
-
Panorama City, CaliforniaMission Community Hospital
Mar 10, 2022
Novel Coronavirus-induced Lung Fibrosis Trial in Chandigarh (Pirfenidone, Nintedanib)
Active, not recruiting
- Novel Coronavirus-induced Lung Fibrosis
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Sep 30, 2022
Covid19, Hydrogen-oxygen Gas, AMS-H-03 Trial in Shanghai (Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, the hospital
Active, not recruiting
- Covid19
- +2 more
- Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
- the hospital routine oxygen supply equipment (wall oxygen or cylinder oxygen)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Medical School of Shanghai Jiaotong University
Sep 13, 2022
Novel Coronavirus Pneumonia Trial (Tanreqing capsule, Tanreqing capsule simulator)
Not yet recruiting
- Novel Coronavirus Pneumonia
- Tanreqing capsule
- Tanreqing capsule simulator
- (no location specified)
Apr 5, 2022
Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases
Active, not recruiting
- Covid19
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 15, 2022
COVID, Corona Virus Infection, Viral Pneumonia Trial in Denmark (Convalescent anti-SARS-CoV-2 plasma, Infusion )
Terminated
- COVID
- +2 more
- Convalescent anti-SARS-CoV-2 plasma
- Infusion placebo
-
Aalborg, Denmark
- +11 more
Aug 2, 2022
COVID-19 Trial in Nanjing (Recombinant COVID-19 vaccine (Sf9 cells), Placebo)
Withdrawn
- COVID-19
- Recombinant COVID-19 vaccine (Sf9 cells)
- Placebo
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Diseases Control and Prevention
May 21, 2021
Coronavirus Trial in Shanghai (MSCs-derived exosomes)
Completed
- Coronavirus
- MSCs-derived exosomes
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Sep 3, 2020
Novel Coronavirus Pneumonia Trial in Shanghai (Fuzheng Huayu tablet)
Completed
- Novel Coronavirus Pneumonia
- Fuzheng Huayu tablet
-
Shanghai, Shanghai, ChinaShuguang Hospital
Nov 25, 2020
Pneumonia, Viral, Covid-19 Trial in Greece (UNIKINON (Chloroquine phosphate) 200mg tablets)
Terminated
- Pneumonia, Viral
- Covid-19
- UNIKINON (Chloroquine phosphate) 200mg tablets
-
Athens, Greece
- +7 more
Sep 16, 2021
Study for Novel Coronavirus Pneumonia (NCP)
Unknown status
- Novel Coronavirus Pneumonia
- systemic treatment
-
Wuhan, Hubei, ChinaUnion hospital
Mar 15, 2020
Novel Coronavirus Pneumonia Trial in Changsha
Unknown status
- Novel Coronavirus Pneumonia
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Mar 16, 2020
Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel
Not yet recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
- (no location specified)
Sep 5, 2023
COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))
Completed
- COVID-19
- Recombinant Novel Coronavirus vaccine (CHO Cells)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 6, 2023
Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant
Active, not recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
-
Wuhu, Anhui, ChinaWannan Medical College Yijishan Hospital
May 6, 2023
Coronavirus Disease 2019, Novel Coronavirus Pneumonia Trial (T89)
Withdrawn
- Coronavirus Disease 2019
- Novel Coronavirus Pneumonia
- (no location specified)
Jun 12, 2020
COVID-19 Trial in Beijing (SA55 nasal spray)
Recruiting
- COVID-19
- SA55 nasal spray
-
Beijing, Chaoyang, ChinaBeijing Ditan Hospital Capital Medical University
Sep 15, 2023
Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With
Active, not recruiting
- COVID-19 Pneumonia
- +4 more
-
Faro, Portugal
- +1 more
Apr 26, 2023
Covid19, Hydrogen-oxygen Gas, AMS-H-03 Trial in Guangzhou (Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, OLO-1 Medical
Unknown status
- Covid19
- +2 more
- Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
- OLO-1 Medical Molecular Sieve Oxygen Generator
-
Guangzhou, Guangdong, China
- +1 more
Oct 19, 2020
COVID-19 Infection Trial in Nanjing, Nantong, Xuzhou (no intervention)
Recruiting
- COVID-19 Infection
- no intervention
-
Nanjing, Jiangsu, China
- +2 more
Jan 28, 2023